Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017 (2017), Article ID 2614602, 8 pages
https://doi.org/10.1155/2017/2614602
Review Article

Future Directions and Molecular Basis of Ventilator Associated Pneumonia

Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey

Correspondence should be addressed to Kubra Aykac

Received 31 January 2017; Accepted 14 September 2017; Published 15 October 2017

Academic Editor: Inmaculada Alfageme

Copyright © 2017 Kubra Aykac et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. 2017, http://www.cdc.gov/nhsn/PDFs/pscManual/10-VAE_FINAL.pdf.
  2. D. M. Kusahara, C. da Cruz Enz, A. F. M. Avelar, M. A. S. Peterlini, M. da Luz, and G. Pedreira, “Risk factors for ventilator-associated pneumonia in infants and children: A crosssectional cohort study,” American Journal of Critical Care, vol. 23, no. 6, pp. 469–476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. F. Patria, G. Chidini, L. Ughi et al., “Ventilator-associated pneumonia in an Italian pediatric intensive care unit: A prospective study,” World Journal of Pediatrics, vol. 9, no. 4, pp. 365–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Chang and A. Schibler, “Ventilator Associated Pneumonia in Children,” Paediatric Respiratory Reviews, vol. 20, pp. 10–16, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Brilli, K. W. Sparling, M. R. Lake et al., “The business case for preventing ventilator-associated pneumonia in pediatric intensive care unit patients,” Joint Commission Journal on Quality and Patient Safety, vol. 34, no. 11, pp. 629–638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. 2017, http://www.cdc.gov/nhsn/pdfs/pscmanual/6pscvapcurrent.pdf.
  7. E. Foglia, M. D. Meier, and A. Elward, “Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients,” Clinical Microbiology Reviews, vol. 20, no. 3, pp. 409–425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Ramirez, M. A. Garcia, M. Ferrer et al., “Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia,” European Respiratory Journal, vol. 31, no. 2, pp. 356–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Said, M. M. Abd-Elaziz, M. M. Farid, M. A. Abd-Elfattah, M. T. Abdel-Monim, and A. Doctor, “Evolution of surfactant protein-D levels in children with ventilator-associated pneumonia,” Pediatric Pulmonology, vol. 47, no. 3, pp. 292–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. İşgüder, G. Ceylan, H. Ağın, G. Gülfidan, Y. Ayhan, and İ. Devrim, “New parameters for childhood ventilator associated pneumonia diagnosis,” Pediatric Pulmonology, vol. 52, no. 1, pp. 119–128, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Almuneef, Z. A. Memish, H. H. Balkhy, H. Alalem, and A. Abutaleb, “Ventilator-associated pneumonia in a pediatric intensive care unit in Saudi Arabia: A 30-month prospective surveillance,” Infection Control and Hospital Epidemiology, vol. 25, no. 9, pp. 753–758, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Elward, D. K. Warren, and V. J. Fraser, “Ventilator-associated pneumonia in pediatric intensive care unit patients: Risk factors and outcomes,” Pediatrics, vol. 109, no. 5, pp. 758–764, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Fayon, M. Tucci, J. Lacroix et al., “Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: A prospective study,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 1, pp. 162–169, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Torres, R. Aznar, J. M. Gatell et al., “Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients,” American Review of Respiratory Disease, vol. 142, no. 3, pp. 523–528, 1990. View at Publisher · View at Google Scholar · View at Scopus
  15. B. D. Albert, D. Zurakowski, L. J. Bechard et al., “Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia∗,” Pediatric Critical Care Medicine, vol. 17, no. 10, pp. 924–929, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Balasubramanian and M. S. Tullu, “Study of Ventilator-Associated Pneumonia in a Pediatric Intensive Care Unit,” The Indian Journal of Pediatrics, vol. 81, no. 11, pp. 1182–1186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Zou, J. Li, S. Xiong et al., “Mortality factor 4 like 1 protein mediates epithelial cell death in a mouse model of pneumonia,” Science Translational Medicine, vol. 7, no. 311, Article ID aac7793, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Bordon, S. Aliberti, R. Fernandez-Botran et al., “Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia,” International Journal of Infectious Diseases, vol. 17, no. 2, pp. e76–e83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Stulik, S. Malafa, J. Hudcova et al., “α-hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 10, pp. 1139–1148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. R. Park, “The microbiology of ventilator-associated pneumonia,” Respiratory Care, vol. 6, pp. 742–763, 2005. View at Google Scholar
  21. G. Tokmaji, H. Vermeulen, M. C. A. Müller, P. H. S. Kwakman, M. J. Schultz, and S. A. J. Zaat, “Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD009201, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Garg, R. Singh, G. Shukla, N. Capalash, and P. Sharma, “Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb,” International Journal of Medical Microbiology, vol. 306, no. 1, pp. 1–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. I. I. Raad, J. A. Mohamed, R. A. Reitzel et al., “The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes,” Biomaterials, vol. 32, no. 11, pp. 2689–2694, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. American Thoracic Society and Infectious Diseases Society of America, “Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 4, pp. 388–416, 2005. View at Publisher · View at Google Scholar
  25. B. J. Williams, J. Dehnbostel, and T. S. Blackwell, “Pseudomonas aeruginosa: Host defence in lung diseases,” Respirology, vol. 15, no. 7, pp. 1037–1056, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. F. Sonnenberg and D. Artis, “Innate lymphoid cells in the initiation, regulation and resolution of inflammation,” Nature Medicine, vol. 21, no. 7, pp. 698–708, 2015. View at Publisher · View at Google Scholar
  27. C. L. MacKall, T. J. Fry, and R. E. Gress, “Harnessing the biology of IL-7 for therapeutic application,” Nature Reviews Immunology, vol. 11, no. 5, pp. 330–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. A. Corfe and C. J. Paige, “The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation,” Seminars in Immunology, vol. 24, no. 3, pp. 198–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Shindo, A. G. Fuchs, C. G. Davis et al., “Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of,” Journal of Leukocyte Biology, vol. 101, no. 2, pp. 543–554, 2017. View at Publisher · View at Google Scholar
  30. J. Unsinger, C.-A. D. Burnham, J. McDonough et al., “Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis,” The Journal of Infectious Diseases, vol. 206, no. 4, pp. 606–616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Pastille, S. Pohlmann, F. Wirsdörfer, A. Reib, and S. B. Flohé, “A disturbed interaction with accessory cells upon opportunistic infection with Pseudomonas aeruginosa contributes to an impaired IFN-γ production of NK cells in the lung during sepsis-induced immunosuppression,” Journal of Innate Immunity, vol. 21, no. 2, pp. 115–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Liu, Y. Feng, K. Yang et al., “Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice,” FEMS Immunology & Medical Microbiology, vol. 61, no. 2, pp. 179–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. K. Stover, X. Q. Pham, A. L. Erwin et al., “Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen,” Nature, vol. 406, no. 6799, pp. 959–964, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. S. L. Gellatly and R. E. W. Hancock, “Pseudomonas aeruginosa: new insights into pathogenesis and host defenses,” Pathogens and Disease, vol. 67, no. 3, pp. 159–173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. A. Driscoll, S. L. Brody, and M. H. Kollef, “The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections,” Drugs, vol. 67, no. 3, pp. 351–368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince, “Pathogen-host interactions in pseudomonas aeruginosa pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 11, pp. 1209–1223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Kyriakis and J. Avruch, “Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation,” Physiological Reviews, vol. 81, no. 2, pp. 807–869, 2001. View at Google Scholar · View at Scopus
  38. Y. Zhang, L.-O. Cardell, L. Edvinsson, and C.-B. Xu, “MAPK/NF-κB-dependent upregulation of kinin receptors mediates airway hyperreactivity: a new perspective for the treatment,” Pharmacological Research, vol. 71, pp. 9–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. T. Diaz-Meco and J. Moscat, “The atypical PKCs in inflammation: NF-κB and beyond,” Immunological Reviews, vol. 246, no. 1, pp. 154–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D. S. Johnson and Y. H. Chen, “Ras family of small GTPases in immunity and inflammation,” Current Opinion in Pharmacology, vol. 12, no. 4, pp. 458–463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. D. Schaller, “Biochemical signals and biological responses elicited by the focal adhesion kinase,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1540, no. 1, pp. 1–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. D. D. Schlaepfer, S. Hou, S.-T. Lim et al., “Tumor necrosis factor-α stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression,” The Journal of Biological Chemistry, vol. 282, no. 24, pp. 17450–17459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Tripathi and A. Sodhi, “Growth hormone-induced production of cytokines in murine peritoneal macrophages in vitro: Role of JAK/STAT, PI3K, PKC and MAP kinases,” Immunobiology, vol. 214, no. 6, pp. 430–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Hou, Y. Nie, B. Cheng et al., “Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa–induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways,” Acta Pharmaceutica Sinica B (APSB), vol. 6, no. 3, pp. 212–221, 2016. View at Publisher · View at Google Scholar
  45. V. B. Cooper and C. Haut, “Preventing ventilator- associated pneumonia in children: An evidence- based protocol,” Critical Care Nurse, vol. 33, no. 3, pp. 21–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Parker and A. Prince, “Immunopathogenesis of Staphylococcus aureus pulmonary infection,” Seminars in Immunopathology, vol. 34, no. 2, pp. 281–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Recsei, B. Kreiswirth, M. O'Reilly, P. Schlievert, A. Gruss, and R. P. Novick, “Regulation of exoprotein gene expression in Staphylococcus aureus by agr,” MGG Molecular & General Genetics, vol. 202, no. 1, pp. 58–61, 1986. View at Publisher · View at Google Scholar · View at Scopus
  48. F. M. Aarestrup, H. D. Larsen, N. H. R. Eriksen, C. S. Elsberg, and N. E. Jensen, “Frequency of α- and β-haemolysin in Staphylococcus aureus of bovine and human origin. A comparison between pheno- and genotype and variation in phenotypic expression,” APMIS-Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 107, no. 4, pp. 425–430, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. C. S. Kim, S.-Y. Jeon, Y.-G. Min et al., “Effects of β-toxin of Staphylococcus aureus on ciliary activity of nasal epithelial cells,” The Laryngoscope, vol. 110, no. 12, pp. 2085–2088, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Hayashida, A. H. Bartlett, T. J. Foster, and P. W. Park, “Staphylococcus aureus beta-toxin induces lung injury through syndecan-1,” The American Journal of Pathology, vol. 174, no. 2, pp. 509–518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Qiu, X. Niu, J. Wang et al., “Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia,” PLoS ONE, vol. 7, no. 3, Article ID e33032, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Wang, J. Dong, X. Dai et al., “Silibinin in vitro protects A549 cells from staphylococcus aureus-mediated injury and in vivo alleviates the lung injury of staphylococcal pneumonia,” Planta Medica, vol. 79, no. 2, pp. 110–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Qiu, M. Luo, J. Wang et al., “Isoalantolactone protects against Staphylococcus aureus pneumonia,” FEMS Microbiology Letters, vol. 324, no. 2, pp. 147–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. C. E. Okolie, A. Cockayne, C. Penfold, and R. James, “Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for Diagnostic and Therapeutic Applications,” BMC Biotechnology, vol. 13, article no. 103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. H. M. Linge, C. Andersson, S. L. Nordin et al., “Midkine is expressed and differentially processed during chronic obstructive pulmonary disease exacerbations and ventilator-associated pneumonia associated with staphylococcus aureus infection,” Molecular Medicine, vol. 19, no. 1, pp. 314–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Achouiti, T. Vogl, A. J. Van Der Meer et al., “Myeloid-related protein-14 deficiency promotes inflammation in staphylococcal pneumonia,” European Respiratory Journal, vol. 46, no. 2, pp. 464–473, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. S. S. Magill, J. R. Edwards, W. Bamberg et al., “Multistate point-prevalence survey of health care-associated infections,” The New England Journal of Medicine, vol. 370, no. 13, pp. 1198–1208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. D. M. Sievert, P. Ricks, J. R. Edwards et al., “Antimicrobial-resistant pathogens associated with healthcare- associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010,” Infection Control and Hospital Epidemiology, vol. 34, no. 1, pp. 1–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. L. S. Munoz-Price, L. Poirel, R. A. Bonomo et al., “Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases,” The Lancet Infectious Diseases, vol. 13, no. 9, pp. 785–796, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Tumbarello, P. Viale, C. Viscoli et al., “Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy,” Clinical Infectious Diseases, vol. 55, no. 7, pp. 943–950, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. C.-R. Lee, J. H. Lee, K. S. Park, Y. B. Kim, B. C. Jeong, and S. H. Lee, “Global dissemination of carbapenemase-producing Klebsiella pneumoniae: Epidemiology, genetic context, treatment options, and detection methods,” Frontiers in Microbiology, vol. 7, article no. 895, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Tängdén and C. G. Giske, “Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control,” Journal of Internal Medicine, vol. 277, no. 5, pp. 501–512, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Nordmann, T. Naas, and L. Poirel, “Global spread of carbapenemase producing Enterobacteriaceae,” Emerging Infectious Diseases, vol. 17, no. 10, pp. 1791–1798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. V. I. Holden, P. Breen, S. Houle, C. M. Dozois, and M. A. Bachman, “Klebsiella pneumoniae siderophores induce inflammation, bacterial dissemination, and HIF-1α stabilization during pneumonia,” mBio, vol. 7, no. 5, Article ID e01397-16, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. M. S. Lawlor, C. O'Connor, and V. L. Miller, “Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection,” Infection and Immunity, vol. 75, no. 3, pp. 1463–1472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. M. A. Bachman, P. Breen, V. Deornellas et al., “Genome-wide identification of Klebsiella pneumoniae fitness genes during lung infection,” mBio, vol. 6, no. 3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. V. I. Holden and M. A. Bachman, “Diverging roles of bacterial siderophores during infection,” Metallomics, vol. 7, no. 6, pp. 986–995, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. V. I. Holden, S. Lenio, R. Kuick, S. K. Ramakrishnan, Y. M. Shah, and M. A. Bachman, “Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells,” Infection and Immunity, vol. 82, no. 9, pp. 3826–3836, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. A. L. Nelson, A. J. Ratner, J. Barasch, and J. N. Weiser, “Interleukin-8 secretion in response to aferric enterobactin is potentiated by siderocalin,” Infection and Immunity, vol. 75, no. 6, pp. 3160–3168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Palazon, A. Goldrath, V. Nizet, and R. Johnson, “HIF transcription factors, inflammation, and immunity,” Immunity, vol. 41, no. 4, pp. 518–528, 2014. View at Publisher · View at Google Scholar
  71. N. V. Kirienko, D. R. Kirienko, J. Larkins-Ford, C. Wählby, G. Ruvkun, and F. M. Ausubel, “Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and death,” Cell Host & Microbe, vol. 13, no. 4, pp. 406–416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. L. K. Siu, K. M. Yeh, J. C. Lin, C. P. Fung, and F. Y. Chang, “Klebsiella pneumoniae liver abscess: a new invasive syndrome,” The Lancet Infectious Diseases, vol. 12, no. 11, pp. 881–885, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. V. L. Yu, D. S. Hansen, C. K. Wen et al., “Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections,” Emerging Infectious Diseases, vol. 13, no. 7, pp. 986–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Canton, D. Neculai, and S. Grinstein, “Scavenger receptors in homeostasis and immunity,” Nature Reviews Immunology, vol. 13, no. 9, pp. 621–634, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. T. F. Olonisakin, H. Li, Z. Xiong et al., “CD36 provides host protection against klebsiella pneumoniae intrapulmonary infection by enhancing lipopolysaccharide responsiveness and macrophage phagocytosis,” The Journal of Infectious Diseases, vol. 214, no. 12, pp. 1865–1875, 2016. View at Publisher · View at Google Scholar · View at Scopus
  76. C. R. Stewart, L. M. Stuart, K. Wilkinson et al., “CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer,” Nature Immunology, vol. 11, no. 2, pp. 155–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Wei, J. Peng, B. Wang et al., “CXCR1/CXCR2 antagonism is effective in pulmonary defense against Klebsiella pneumoniae infection,” BioMed Research International, vol. 2013, Article ID 720975, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. B. B. Aggarwal, S. Shishodia, S. K. Sandur, M. K. Pandey, and G. Sethi, “Inflammation and cancer: how hot is the link?” Biochemical Pharmacology, vol. 72, no. 11, pp. 1605–1621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. X. Zhao, J. R. Town, F. Li, W. Li, X. Zhang, and J. R. Gordon, “Blockade of neutrophil responses in aspiration pneumonia via ELR-CXC chemokine antagonism does not predispose to airway bacterial outgrowth,” Pulmonary Pharmacology and Therapeutics, vol. 23, no. 1, pp. 22–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. X. Zhao, J. R. Town, A. Yang et al., “A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury,” Journal of Surgical Research, vol. 162, no. 2, pp. 264–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. B. A. Almomani, A. McCullough, R. Gharaibeh, S. Samrah, and F. Mahasneh, “Incidence and predictors of 14-day mortality in multidrug-resistant Acinetobacter baumannii in ventilator-associated pneumonia,” The Journal of Infection in Developing Countries, vol. 9, no. 12, pp. 1323–1330, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. N. M. Elhosseiny, M. A. Amin, A. S. Yassin, and A. S. Attia, “Acinetobacter baumannii universal stress protein A plays a pivotal role in stress response and is essential for pneumonia and sepsis pathogenesis,” International Journal of Medical Microbiology, vol. 305, no. 1, pp. 114–123, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. A. C. Jacobs, I. Hood, K. L. Boyd et al., “Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis,” Infection and Immunity, vol. 78, no. 5, pp. 1952–1962, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. J. A. Méndez, J. Mateos, A. Beceiro et al., “Quantitative proteomic analysis of host-pathogen interactions: a study of Acinetobacter baumannii responses to host airways,” BMC Genomics, vol. 16, no. 1, article no. 422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. L. J. Juttukonda, W. J. Chazin, and E. P. Skaar, “Acinetobacter baumannii coordinates urea metabolism with metal import to resist host-mediated metal limitation,” mBio, vol. 7, no. 5, Article ID e01475-16, 2016. View at Publisher · View at Google Scholar · View at Scopus
  86. M. I. Hood, R. Uzhachenko, K. Boyd, E. P. Skaar, and A. V. Ivanova, “Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection,” Infection and Immunity, vol. 81, no. 12, pp. 4461–4469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Chastre and J. Fagon, “Ventilator-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 867–903, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Messika, F. Magdoud, O. Clermont et al., “Pathophysiology of Escherichia coli ventilator-associated pneumonia: Implication of highly virulent extraintestinal pathogenic strains,” Intensive Care Medicine, vol. 38, no. 12, pp. 2007–2016, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. N. Dufour, L. Debarbieux, M. Fromentin, and J.-D. Ricard, “Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia with Bacteriophages,” Critical Care Medicine, vol. 43, no. 6, pp. e190–e198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. http://www.medscape.com/viewarticle/717400.
  91. L. J. Quinton, M. R. Jones, B. E. Robson, B. T. Simms, J. A. Whitsett, and J. P. Mizgerd, “Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia,” American Journal of Respiratory Cell and Molecular Biology, vol. 38, no. 6, pp. 699–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. X. Cui, F. Zeni, Y. Vodovitz et al., “TGF-β1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats,” Cytokine, vol. 24, no. 4, pp. 115–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. X. Su, M. Johansen, M. R. Looney, E. J. Brown, and M. A. Matthay, “CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia,” The Journal of Immunology, vol. 180, no. 10, pp. 6947–6953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. Q. Wang, P. Teder, N. P. Judd, P. W. Noble, and C. M. Doerschuk, “CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice,” The American Journal of Pathology, vol. 161, no. 6, pp. 2219–2228, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Seki, K. Fukunaga, M. Arita et al., “The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury,” The Journal of Immunology, vol. 184, no. 2, pp. 836–843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. A. V. Kostiushko and E. V. Markelova, “The cytokines profiles at the enterobacter pneumonia during experiment,” Pathologicheskaia Fiziologiia i Eksperimental'naia Terapiia, vol. 4, pp. 27–30, 2010. View at Google Scholar